Trial Profile
The Impact of Nursing and Pharmacy Care Between Capecitabine and 5-Fluoruracil Regimens in the Management of Advanced Esophago-gastric Cancer in Hong Kong
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 06 Feb 2017
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 01 Feb 2017 Status changed from active, no longer recruiting to withdrawn prior to enrolment due to slow recruitment pace.
- 15 Mar 2014 New trial record